Loading stock data...

Jeevan Scientific Technology Limited

BSE: JSTL

BSE
42.31 0.20 (0.47%)

Prev Close

42.11

Open Price

43.99

Volume

221

Today Low / High

41.15 / 43.99

52 WK Low / High

36.5 / 57.8

Range

40 - 44

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 42.31, reflecting a change of 0.2 (0.47495%). The expected target range on the BSE is 40 - 44. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

06 Aug 40.69 0.76%
05 Aug 40.94 -2.56%
04 Aug 41.00 -2.44%
01 Aug 40.99 -4.66%
31 Jul 41.40 -4.93%
30 Jul 39.00 1.00%
29 Jul 41.83 -5.50%
28 Jul 40.50 -2.22%
25 Jul 40.98 0.78%
24 Jul 40.37 -0.84%
23 Jul 39.90 -0.80%
22 Jul 41.00 -1.49%
21 Jul 40.99 -3.39%

Jeevan Scientific Technology Limited Graph

Jeevan Scientific Technology Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Jeevan Scientific Technology Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 42.31, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 42.31 42.73 38.46 - 47.01
43.16 34.52 - 51.79
43.58 30.51 - 56.65
Bearish Scenario 42.31 41.89 37.70 - 46.08
41.46 33.17 - 49.76
41.04 28.73 - 53.35

Overview of Jeevan Scientific Technology Limited

ISIN

INE237B01018

Industry

Medical - Care Facilities

Vol.Avg

8,682

Market Cap

649,194,000

Last Dividend

0

Official Website

Visit Website

IPO Date

DCF Diff

N/A

DCF

0

Financial Ratios Every Investor Needs

Stock Dividend of JSTL

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2022-09-21 September 21, 22 1.2 1.2 2022-09-22 2022-10-29
2021-09-07 September 07, 21 0.5 0.5 2021-09-08 2021-10-15

Stock Rating Details for JSTL

Metric Value Recommendation
Overall Rating C Sell
DCF Score 1 Strong Sell
ROE Score 2 Sell
ROA Score 3 Neutral
Debt-to-Equity (DE) Score 2 Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 46.84 Cr 3.80 Cr 43.04 Cr 0.9188 0.00 Cr 0.00 Cr 1.16 Cr 0.13 Cr 0.08 8.06 Cr 0.0029
2024-03-31 39.65 Cr 25.30 Cr 14.35 Cr 0.3618 0.00 Cr 3.06 Cr -1.24 Cr -1.30 Cr -0.84 5.34 Cr -0.0327
2023-03-31 36.18 Cr 3.00 Cr 33.18 Cr 0.9170 0.00 Cr 2.38 Cr -3.62 Cr -3.05 Cr -1.98 2.41 Cr -0.0843
2022-03-31 67.79 Cr 7.39 Cr 60.40 Cr 0.8909 0.00 Cr 9.13 Cr 13.14 Cr 11.94 Cr 7.81 22.68 Cr 0.1762
2021-03-31 47.48 Cr 0.64 Cr 46.84 Cr 0.9865 0.00 Cr 4.63 Cr 14.06 Cr 11.74 Cr 7.67 19.82 Cr 0.2473

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.24 Cr 78.29 Cr 28.22 Cr 49.9437 Cr 20.58 Cr 20.34 Cr 1.62 Cr 32.39 Cr 0.00 Cr 0.00 Cr 0.00 Cr 12.0705 Cr
2024-03-31 0.54 Cr 67.87 Cr 19.23 Cr 48.4284 Cr 13.41 Cr 12.87 Cr 1.80 Cr 36.02 Cr 0.54 Cr 0.00 Cr 0.00 Cr 9.2080 Cr
2023-03-31 6.83 Cr 65.92 Cr 17.50 Cr 48.1896 Cr 10.10 Cr 3.26 Cr 0.87 Cr 29.42 Cr 1.09 Cr 0.00 Cr -4.64 Cr 11.3895 Cr
2022-03-31 29.71 Cr 77.88 Cr 27.30 Cr 50.5831 Cr 12.54 Cr -17.17 Cr 1.46 Cr 18.45 Cr 0.00 Cr 0.00 Cr 0.00 Cr 22.2948 Cr
2021-03-31 3.26 Cr 65.98 Cr 30.95 Cr 35.0228 Cr 10.35 Cr 7.09 Cr 3.46 Cr 15.94 Cr 0.00 Cr 0.00 Cr 0.00 Cr 22.8648 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 10.0729 Cr -15.6199 Cr 5.2448 Cr -5.9585 Cr -0.3022 Cr 0.2423 Cr -16.0314 Cr 0.0507 Cr 4.3608 Cr 0.0000 Cr -0.5283 Cr
2024-03-31 2.8919 Cr -11.5276 Cr 2.3464 Cr -9.1371 Cr -6.2893 Cr 0.5445 Cr -12.0290 Cr -1.6039 Cr 4.3423 Cr 0.0000 Cr -0.2183 Cr
2023-03-31 -6.4052 Cr -6.9309 Cr -9.5435 Cr -17.0474 Cr -22.8795 Cr 6.8338 Cr -8.1628 Cr -3.6827 Cr -6.1037 Cr -1.8362 Cr 0.5840 Cr
2022-03-31 19.5614 Cr -1.2044 Cr 5.6716 Cr 17.3301 Cr 24.0285 Cr 29.7133 Cr -2.3423 Cr 18.3489 Cr -3.3975 Cr -0.7651 Cr 3.4881 Cr
2021-03-31 4.9471 Cr -0.7990 Cr -0.1328 Cr 4.1481 Cr 4.0153 Cr 6.2115 Cr -0.7990 Cr 13.6496 Cr -0.1328 Cr 0.0000 Cr -2.5090 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-03-31 10.06 Cr 1.15 Cr 8.90 Cr 0.8853 -2.15 Cr -1.30 Cr -0.82 -0.24 Cr -0.1292
2024-12-31 12.51 Cr 0.85 Cr 11.65 Cr 0.9318 0.60 Cr 0.11 Cr 0.07 2.30 Cr 0.0084
2024-09-30 11.40 Cr 0.80 Cr 10.59 Cr 0.9294 1.00 Cr 0.24 Cr 0.16 2.66 Cr 0.0209
2024-06-30 12.88 Cr 6.49 Cr 6.39 Cr 0.4960 1.71 Cr 1.09 Cr 0.66 3.34 Cr 0.0846
2024-03-31 11.07 Cr 7.07 Cr 4.00 Cr 0.3614 -0.66 Cr -0.73 Cr -0.47 1.21 Cr -0.0662

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 0.24 Cr 1.55 Cr 1.79 Cr 15.94 Cr 1.62 Cr 28.76 Cr 32.39 Cr 78.29 Cr 28.22 Cr
2024-12-31 0.00 Cr 0.00 Cr 2.56 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -50.25 Cr
2024-09-30 2.56 Cr 1.55 Cr 4.11 Cr 13.72 Cr 1.35 Cr 26.40 Cr 27.81 Cr 73.14 Cr 22.89 Cr
2024-06-30 0.00 Cr 0.00 Cr 0.54 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -48.63 Cr
2024-03-31 0.54 Cr 2.98 Cr 0.54 Cr 17.33 Cr 1.09 Cr 24.67 Cr 36.02 Cr 67.87 Cr 19.23 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2024-12-31 0.11 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 0.24 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 1.09 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 -0.73 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-12-31 -0.48 Cr 2.79 Cr 0.00 Cr 0.00 Cr 2.79 Cr 9.24 Cr 6.45 Cr 0.00 Cr 2.79 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Care Facilities

Company Name Symbol Price Market Cap Volume
Max Healthcare Institute Limited MAXHEALTH ₹1,267.10 ₹1,231,807,463,700.00 ₹3,268,156.00
Apollo Hospitals Enterprise Limited APOLLOHOSP ₹7,808.50 ₹1,122,745,172,500.00 ₹2,291,517.00
Fortis Healthcare Limited FORTIS ₹945.80 ₹714,039,276,400.00 ₹3,009,896.00
Narayana Hrudayalaya Limited NH ₹1,830.90 ₹374,164,554,900.00 ₹273,294.00
Global Health Limited MEDANTA ₹1,355.60 ₹364,223,150,240.00 ₹225,680.00
Aster DM Healthcare Limited ASTERDM ₹613.05 ₹317,634,079,050.00 ₹829,508.00
Krishna Institute of Medical Sciences Limited KIMS ₹731.20 ₹292,581,636,800.00 ₹294,308.00
Rainbow Children's Medicare Limited RAINBOW ₹1,548.20 ₹157,222,301,687.00 ₹178,331.00
HealthCare Global Enterprises Limited HCG ₹681.35 ₹94,990,410,250.00 ₹197,314.00
Yatharth Hospital & Trauma Care Services Limited YATHARTH ₹714.85 ₹68,878,910,672.00 ₹651,708.00
Indraprastha Medical Corporation Limited INDRAMEDCO ₹467.70 ₹42,875,462,100.00 ₹123,823.00
Kovai Medical Center and Hospital Limited KOVAI ₹2,581.00 ₹35,290,787,300.00 ₹5,780.00
Artemis Medicare Services Limited ARTEMISMED ₹241.54 ₹33,549,906,000.00 ₹105,330.00

Key Executives

Chief Operating Officer
Mr. Chakrapani Achutha Majumdar

Gender: male

Year Born: 1977

Chief Executive Officer
Dr. Srinivas Reddy Maram

Gender: Not Specified

Year Born:

Company Secretary & Compliance Officer
Mr. Krishna Sainadh Kodati

Gender: male

Year Born:

Executive Director of Administration & Executive Director
Mr. Yarllagadda Nageswara Rao

Gender: male

Year Born: 1956

Executive Vice Chairman & MD
Mr. Krishna Kishore Kuchipudi

Gender: male

Year Born: 1960

Executive Director
Ms. Snigdha Mothukuri

Gender: female

Year Born: 1992

Chief Financial Officer
Mr. Venkateswara Rao Ravipati

Gender: male

Year Born: 1978

FAQs about Jeevan Scientific Technology Limited

Who is the CEO of the company?

The CEO is Srinivas Reddy Maram.

What is the current market price of the stock?

The current price is ₹41.00.

What is the 52-week price range?

The range is ₹36.5-57.8.

What is the market capitalization of the company?

The market capitalization is ₹64.92 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 480.23.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Jeevan Scientific Technology Limited (ISIN: INE237B01018) is a leading Medical - Care Facilities in India. With a market capitalization of ₹64.92 crores and an average daily volume of 8,682 shares, it operates in the Medical - Care Facilities. The company last declared a dividend of ₹0.

Welcome to the Investing and Trading Information platform: InvesTrack.in

Note: This platform is for educational and informational purposes only. Do not consider anything as financial advice.

QUICK LINKS

Home
About us
Contact us
Privacy Policy
Disclaimer
Sitemap
Investing
Trading
Top Brokers
Tools
Live Analysis

STAY CONNECTED

Follow Us On Social Media
Get Latest Update On Social Media
Facebook Instagram Twitter

General Disclaimer: InvesTrack is an educational platform and not any type of investment advisory platform. Our Blog and videos are based on countless hours of research and experience, which you can use as a guide for your research purposes. None of our content should be considered a piece of investment advice. Earning Disclosure: InvesTrack is a community supported platform. We may earn a commission when you make a purchase through one of our links at no extra cost to you. Note: We are not SEBI Registered Advisors. This website is purely for training and educational purposes. We shall not be responsible for your profit or loss.

© Copyright 2024 - 2025 | InvesTrack